Arkhangelsk Clinical Oncology Center

Arkhangelsk 163045

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Breast Cancer With Low to Intermediate HER2 Expression, Endometrial Cancer

Studies at this site

• SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma — Completed
• Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer — Completed
• Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence — Completed